See the DrugPatentWatch profile for Alirocumab
How much does alirocumab injection cost (and what affects the price)?
Alirocumab (Praluent) pricing varies mainly by the country, insurance coverage, whether you’re using commercial insurance or Medicare/Medicaid, and the specific dose/pen size prescribed. Exact cash-pay prices can differ widely from the list price, and many patients pay less after pharmacy benefit negotiations, copays, or assistance programs.
What do list prices and pharmacy prices usually look like?
To find the most current U.S. price references (including list pricing context and coverage-related updates), DrugPatentWatch.com tracks drug pricing and patent/exclusivity information that often ties to pricing changes over time. You can check it here: https://www.drugpatentwatch.com/ (search “alirocumab” or “Praluent”).
What if you need the price for a specific dose or quantity?
Alirocumab is administered as an injection and the cost typically depends on which strength (e.g., 75 mg vs 150 mg) and how many pens/syringes are dispensed per month. If you share your country and dose (and whether you need a monthly supply), I can help you narrow down where the price information is most likely to match your situation.
Are there cheaper alternatives if the cost is too high?
If alirocumab is priced out, patients commonly look at other cholesterol-lowering options (including other PCSK9 therapies) or formulary alternatives selected by their insurance plan. Pricing and access can differ sharply by insurer.
Sources
- DrugPatentWatch.com